Literature DB >> 30076568

Grade 3 Neuroendocrine Tumor (G3 NET) in a Background of Multiple Serotonin Cell Neoplasms of the Ileum Associated with Carcinoid Syndrome and Aggressive Behavior.

Francesca Capuano1, Oneda Grami1, Luigi Pugliese2, Marco Paulli1, Andrea Pietrabissa2, Enrico Solcia1, Alessandro Vanoli3.   

Abstract

Grade 3 well-differentiated neuroendocrine tumors (G3 NETs) have been characterized in the pancreas and stomach and distinguished from low-to-intermediate grade (G1-G2) NETs, as well as from highly malignant, poorly differentiated neuroendocrine carcinomas (NECs). Up to now, no G3 NET has been thoroughly described in the distal small intestine. We herein report a case of a 61-year-old man presenting with carcinoid syndrome. The surgical specimen showed, in a background of small G1 ileal NETs, a larger, grade 3 NET, which retained the nesting pattern and the expression of serotonin, chromogranin-A, and type 2A somatostatin receptors, typical of well-differentiated jejuno-ileal NETs. The patient had G3 NET metastasis to the liver and he died 14 months after surgery, due to deterioration in his clinical conditions.

Entities:  

Keywords:  G3 neuroendocrine tumor; Grading; Prognosis; Small intestine neuroendocrine tumors

Mesh:

Year:  2018        PMID: 30076568     DOI: 10.1007/s12022-018-9541-8

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  15 in total

1.  Well-Differentiated Neuroendocrine Tumors with a Morphologically Apparent High-Grade Component: A Pathway Distinct from Poorly Differentiated Neuroendocrine Carcinomas.

Authors:  Laura H Tang; Brian R Untch; Diane L Reidy; Eileen O'Reilly; Deepti Dhall; Lily Jih; Olca Basturk; Peter J Allen; David S Klimstra
Journal:  Clin Cancer Res       Date:  2015-10-19       Impact factor: 12.531

2.  A Hereditary Form of Small Intestinal Carcinoid Associated With a Germline Mutation in Inositol Polyphosphate Multikinase.

Authors:  Yoshitatsu Sei; Xilin Zhao; Joanne Forbes; Silke Szymczak; Qing Li; Apurva Trivedi; Mark Voellinger; Grishma Joy; Jianying Feng; Millie Whatley; MaryPat Sussex Jones; Ursula L Harper; Stephen J Marx; Aradhana M Venkatesan; Settara C Chandrasekharappa; Mark Raffeld; Martha M Quezado; Adeline Louie; Clara C Chen; Ramona M Lim; Richa Agarwala; Alejandro A Schäffer; Marybeth S Hughes; Joan E Bailey-Wilson; Stephen A Wank
Journal:  Gastroenterology       Date:  2015-04-09       Impact factor: 22.682

3.  Somatostatin receptor expression related to TP53 and RB1 alterations in pancreatic and extrapancreatic neuroendocrine neoplasms with a Ki67-index above 20.

Authors:  Björn Konukiewitz; Anna Melissa Schlitter; Moritz Jesinghaus; Dominik Pfister; Katja Steiger; Angela Segler; Abbas Agaimy; Bence Sipos; Giuseppe Zamboni; Wilko Weichert; Irene Esposito; Nicole Pfarr; Günter Klöppel
Journal:  Mod Pathol       Date:  2017-01-06       Impact factor: 7.842

4.  CDX2 as a marker of intestinal EC-cells and related well-differentiated endocrine tumors.

Authors:  Stefano La Rosa; Elena Rigoli; Silvia Uccella; Anna Maria Chiaravalli; Carlo Capella
Journal:  Virchows Arch       Date:  2004-07-29       Impact factor: 4.064

5.  Somatostatin receptor type 2A immunohistochemistry in neuroendocrine tumors: a proposal of scoring system correlated with somatostatin receptor scintigraphy.

Authors:  Marco Volante; Maria Pia Brizzi; Antongiulio Faggiano; Stefano La Rosa; Ida Rapa; Anna Ferrero; Gelsomina Mansueto; Luisella Righi; Silvana Garancini; Carlo Capella; Gaetano De Rosa; Luigi Dogliotti; Annamaria Colao; Mauro Papotti
Journal:  Mod Pathol       Date:  2007-09-14       Impact factor: 7.842

6.  Solitary versus multiple carcinoid tumors of the ileum: a clinical and pathologic review of 68 cases.

Authors:  Rhonda K Yantiss; Robert D Odze; Francis A Farraye; Andrew E Rosenberg
Journal:  Am J Surg Pathol       Date:  2003-06       Impact factor: 6.394

7.  miRNA profiling of small intestinal neuroendocrine tumors defines novel molecular subtypes and identifies miR-375 as a biomarker of patient survival.

Authors:  Yvonne Arvidsson; Anna Rehammar; Anders Bergström; Ellinor Andersson; Gülay Altiparmak; Christina Swärd; Bo Wängberg; Erik Kristiansson; Ola Nilsson
Journal:  Mod Pathol       Date:  2018-02-27       Impact factor: 7.842

8.  Prognostic Evaluations Tailored to Specific Gastric Neuroendocrine Neoplasms: Analysis Of 200 Cases with Extended Follow-Up.

Authors:  Alessandro Vanoli; Stefano La Rosa; Emanuela Miceli; Catherine Klersy; Roberta Maragliano; Francesca Capuano; Andrea Persichella; Michele Martino; Frediano Inzani; Ombretta Luinetti; Antonio Di Sabatino; Fausto Sessa; Marco Paulli; Gino Roberto Corazza; Guido Rindi; Cesare Bordi; Carlo Capella; Enrico Solcia
Journal:  Neuroendocrinology       Date:  2018-06-12       Impact factor: 4.914

9.  The Influence of Tumor Stage on the Prognostic Value of Ki-67 Index and Mitotic Count in Small Intestinal Neuroendocrine Tumors.

Authors:  Yu Sun; Christine Lohse; Thomas Smyrk; Timothy Hobday; Trynda Kroneman; Lizhi Zhang
Journal:  Am J Surg Pathol       Date:  2018-02       Impact factor: 6.394

10.  Prognostic Impact of Novel Molecular Subtypes of Small Intestinal Neuroendocrine Tumor.

Authors:  Anna Karpathakis; Harpreet Dibra; Chistodoulos Pipinikas; Andrew Feber; Tiffany Morris; Joshua Francis; Dahmane Oukrif; Dalvinder Mandair; Marinos Pericleous; Mullan Mohmaduvesh; Stefano Serra; Olagunju Ogunbiyi; Marco Novelli; TuVinh Luong; Sylvia L Asa; Matthew Kulke; Christos Toumpanakis; Tim Meyer; Martyn Caplin; Matthew Meyerson; Stephan Beck; Christina Thirlwell
Journal:  Clin Cancer Res       Date:  2015-07-13       Impact factor: 12.531

View more
  4 in total

Review 1.  Genomics of High-Grade Neuroendocrine Neoplasms: Well-Differentiated Neuroendocrine Tumor with High-Grade Features (G3 NET) and Neuroendocrine Carcinomas (NEC) of Various Anatomic Sites.

Authors:  Silvia Uccella; Stefano La Rosa; Jasna Metovic; Deborah Marchiori; Jean-Yves Scoazec; Marco Volante; Ozgur Mete; Mauro Papotti
Journal:  Endocr Pathol       Date:  2021-01-12       Impact factor: 3.943

Review 2.  Neuroendocrine neoplasia of the gastrointestinal tract revisited: towards precision medicine.

Authors:  Guido Rindi; Bertram Wiedenmann
Journal:  Nat Rev Endocrinol       Date:  2020-08-24       Impact factor: 43.330

3.  An analysis of 130 neuroendocrine tumors G3 regarding prevalence, origin, metastasis, and diagnostic features.

Authors:  Atsuko Kasajima; Björn Konukiewitz; Anna Melissa Schlitter; Wilko Weichert; Günter Klöppel
Journal:  Virchows Arch       Date:  2021-09-09       Impact factor: 4.064

4.  Grade 3 well-differentiated neuroendocrine tumor of the rectum: a case report.

Authors:  Misato Ito; Yasumitsu Hirano; Toshimasa Isii; Hiroka Kondo; Liming Wang; Masahiro Asari; Nao Obara; Shigeki Yamaguchi
Journal:  Surg Case Rep       Date:  2020-06-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.